Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05856786
Other study ID # 0262-22-EP
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 1, 2024
Est. completion date December 31, 2024

Study information

Verified date May 2024
Source University of Nebraska
Contact Pukhraj P Rishi, MBBS
Phone 402-559-2020
Email pukhraj.rishi@unmc.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Corrective eye surgeries, such as Lasik, are widely used to correct focusing problems such as myopia, or nearsightedness. Often these patients develop other conditions like myopic maculopathy or glaucoma which require monitoring with optical coherence tomography (OCT). Since OCT is a light-based test and changes the refractive status of the eye (in the cornea or the lens), it can potentially affect the results of the OCT measurements but has not been sufficiently studied. This pilot study aims at studying the potential change in OCT parameters in the eye after undergoing such surgery.


Description:

Refractive surgeries are widely used in patients with ametropia. Refractive surgery is most commonly performed in patients with myopia. These patients often have a predilection for developing other conditions in the posterior segment of the eye, like myopic maculopathy or glaucoma which require monitoring with optical coherence tomography (OCT). Since OCT is a light-based test and changes in the refractive status of the eye (in the cornea or the lens) can potentially affect the results of the OCT measurements. Literature review reveals that the effect of significant changes in refractive power of the eye on the parameters of optical coherence tomography (OCT) has not been sufficiently studied. Some authors simulated the effect of refractive surgery using a contact lens but had diverging results. This prospective pilot study aims at studying the potential change in OCT parameters in the eye after undergoing refractive surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 33
Est. completion date December 31, 2024
Est. primary completion date November 30, 2024
Accepts healthy volunteers
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: 1. Patients undergoing refractive surgery 2. For patients undergoing bilateral eye surgery, the one with higher degree of ametropia will be included. Exclusion Criteria: 1. Astigmatism more than 3 Diopters 2. Visual acuity worse than 20/25 3. Patients with unstable visual fixation 4. Severe Dry Eye

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Optical coherence tomography
Posterior segment OCT (a non-contact procedure performed over one minute) is additionally performed for patients participating in this study. Proportion of change in measurements in microns will be analyzed.

Locations

Country Name City State
United States Unversity of Nebraska Medical Center Omaha Nebraska

Sponsors (1)

Lead Sponsor Collaborator
University of Nebraska

Country where clinical trial is conducted

United States, 

References & Publications (4)

Chen Y, Liao H, Sun Y, Shen X. Short-term changes in the anterior segment and retina after small incision lenticule extraction. BMC Ophthalmol. 2020 Oct 7;20(1):397. doi: 10.1186/s12886-020-01668-7. — View Citation

Ozsaygili C, Altunel O, Duru N. Evaluation of the change in retinal thickness after femtosecond laser-assisted laser in situ keratomileusis and photorefractive keratectomy. Curr Eye Res. 2022 Jan;47(1):18-24. doi: 10.1080/02713683.2021.1951297. Epub 2021 — View Citation

Shpak AA, Kostenev SV, Mushkova IA, Korobkova MV. [Effect of corneal refractive surgery on optical coherence tomography measurements]. Vestn Oftalmol. 2018;134(5):48-53. doi: 10.17116/oftalma201813405148. Russian. — View Citation

Yalcinkaya G, Yildiz BK, Cakir I, Yildirim Y, Demirok A. Evaluation of peripapillary - macular microvascularity and choroidal vascularity index after refractive surgery. Photodiagnosis Photodyn Ther. 2022 Mar;37:102714. doi: 10.1016/j.pdpdt.2022.102714. E — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Macular thickness Proportion of Change in thickness of retina and its layers measured in microns 1 day after refractive procedure
Primary Macular thickness Proportion of Change in thickness of retina and its layers measured in microns 1 week after refractive procedure
Secondary Choroidal thickness Proportion of Change in thickness of choroid and its layers measured in microns 1 day after refractive procedure
Secondary Choroidal thickness Proportion of Change in thickness of choroid and its layers measured in microns 1 week after refractive procedure
Secondary visual acuity Proportion of Change in clarity of vision, measured in logarithm of Minimal Angle of Resolution (logMAR) units 1 day after refractive procedure
Secondary visual acuity Proportion of Change in clarity of vision, measured in logarithm of Minimal Angle of Resolution (logMAR) units 1 week after refractive procedure
Secondary central corneal thickness Proportion of Change in thickness of cornea measured in microns 1 day after refractive procedure
Secondary central corneal thickness Proportion of Change in thickness of cornea measured in microns 1 week after refractive procedure
Secondary anterior chamber depth Proportion of Change in depth of anterior chamber of the eye measured in microns 1 day after refractive procedure
Secondary anterior chamber depth Proportion of Change in depth of anterior chamber of the eye measured in microns 1 week after refractive procedure
Secondary keratometry Proportion of Change in corneal curvature measured in diopters 1 day after refractive procedure
Secondary keratometry Proportion of Change in corneal curvature measured in diopters 1 week after refractive procedure
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04923841 - Myopia Control Using Bright Light Therapy, Myopic Defocus and Atropine N/A
Active, not recruiting NCT04080128 - Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control N/A
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Completed NCT04604405 - Effects of 650nm Low Energy Light on Human Retina and Choroid Microcirculation N/A
Recruiting NCT05594719 - The Effect of Sun-like Spectrum With Different Spectrum Composition on Retinal Blood Flow N/A
Completed NCT05594732 - The Effects of Different Outdoor Light Exposure Modes on Retinal Blood Flow N/A
Completed NCT04492397 - Comparing The Performance Of Two Different Daily Disposable Lenses (MIKI) N/A
Completed NCT04536571 - Vision Stability and Preference for Soft Toric vs. Soft Spherical Contact Lenses N/A
Completed NCT06046209 - Comparing a Monthly Replacement Lens Versus a Daily Disposable Lens N/A
Recruiting NCT06344572 - Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia Phase 3
Recruiting NCT05611294 - Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction N/A
Completed NCT05656885 - Clinical Evaluation of Two Frequent Replacement Soft Spherical Contact Lenses N/A
Active, not recruiting NCT05534022 - Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression. N/A
Completed NCT03934788 - the Clinical Performance of the Oxysoft Daily Disposable Silicone Hydrogel Soft Contact Lens N/A
Completed NCT03701516 - Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2 N/A
Completed NCT05538754 - Post-Market Evaluation of the EVO ICL N/A
Completed NCT03139201 - Clinical Performance of the OxyAqua Daily Disposable Silicone Hydrogel Soft Contact Lens N/A
Completed NCT02555722 - Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear N/A
Not yet recruiting NCT06009458 - Acuity 200™ (Fluoroxyfocon A) Orthokeratology Contact Lens for Overnight Wear N/A
Recruiting NCT05548478 - Corneal Endothelial Cell Injury Induced by Mitomycin-C N/A